1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Cohort 2: Dose Escalation: new trials by email Literature Review of Cohort 2: Dose Escalation trials Research Report on Cohort 2: Dose Escalation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients Cohort 1: Dose Escalation, Cohort 2: Dose Escalation - Ovarian Cancer, Resistant BRCA Wild-Type Ovarian Cancer | Phase 1 | Terminated | University of Alabama at Birmingham | 1 | 2021-09-01 | 2023-11-21 |
University of Alabama at Birmingham (1)
United States (1)